Last edition
News about "Medicines and Healthcare Products Regulatory Agenc"
Sitryx receives FDA clearance of IND application for SYX-5219 for the treatment of atopic dermatitis
Sitryx’s SYX-5219 is a first-in-class, oral, disease-modifying, anti-inflammatory therapy, targeting pyruvate kinase M2 (PKM2), a critical enzyme that regulates cell metabolism.
Medicines And Healthcare Products Regulatory Agenc | 04/10/2025 | By Dineshwori | 119
BrePco and Piramal Receive UK MHRA Approval for Neoatricon Paediatric Dopamine Formula
Neoatricon, developed by BrePco Biopharma, is an age-appropriate, ready-to-use, sterile solution available in two concentrations: 1.5 mg/mL in a 30 mL vial and a higher strength of 4.5 mg/mL in a 50 mL vial.
Medicines And Healthcare Products Regulatory Agenc | 24/03/2025 | By Aishwarya | 196
CuraTeQ Biologics Secures UK MHRA Approval for Bevqolva
Bevqolva 25 mg/mL concentrate for infusion will be available in 4 mL (100 mg) and 16 mL (400 mg) single-use vials for infusion into veins.
Medicines And Healthcare Products Regulatory Agenc | 23/12/2024 | By Aishwarya | 430
Moderna Gets MHRA Authorization for Updated COVID-19 Vaccine
For the first time in the UK, the updated vaccine, Spikevax JN.1, will also be available to purchase privately for those who are not eligible for the NHS Autumn vaccination program.
Medicines And Healthcare Products Regulatory Agenc | 05/09/2024 | By Aishwarya | 282
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy